123 related articles for article (PubMed ID: 27380428)
1. POSTERIOR EYE SEGMENT COMPLICATIONS RELATED TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION.
Yoo YS; Na KS; Shin JA; Park YH; Lee JW
Retina; 2017 Jan; 37(1):135-143. PubMed ID: 27380428
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors of cytomegalovirus retinitis after hematopoietic stem cell transplantation.
Kim JY; Hong SY; Park WK; Kim RY; Kim M; Park YG; Kim HJ; Lee S; Lee DG; Park YH
PLoS One; 2020; 15(9):e0238257. PubMed ID: 32877457
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for cytomegalovirus retinitis in patients with cytomegalovirus viremia after hematopoietic stem cell transplantation.
Jeon S; Lee WK; Lee Y; Lee DG; Lee JW
Ophthalmology; 2012 Sep; 119(9):1892-8. PubMed ID: 22657564
[TBL] [Abstract][Full Text] [Related]
4. Frequent occurrence of cytomegalovirus retinitis during immune reconstitution warrants regular ophthalmic screening in high-risk pediatric allogeneic hematopoietic stem cell transplant recipients.
Hiwarkar P; Gajdosova E; Qasim W; Worth A; Breuer J; Chiesa R; Ridout D; Edelsten C; Moore A; Amrolia P; Veys P; Rao K
Clin Infect Dis; 2014 Jun; 58(12):1700-6. PubMed ID: 24700657
[TBL] [Abstract][Full Text] [Related]
5. Ocular findings after allogeneic hematopoietic stem cell transplantation.
Tabbara KF; Al-Ghamdi A; Al-Mohareb F; Ayas M; Chaudhri N; Al-Sharif F; Al-Zahrani H; Mohammed SY; Nassar A; Aljurf M
Ophthalmology; 2009 Sep; 116(9):1624-9. PubMed ID: 19729097
[TBL] [Abstract][Full Text] [Related]
6. Ocular complications in children within 1 year after hematopoietic stem cell transplantation.
Kalinina Ayuso V; Hettinga Y; van der Does P; Boelens JJ; Rothova A; de Boer J
JAMA Ophthalmol; 2013 Apr; 131(4):470-5. PubMed ID: 23450391
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus Retinitis in Pediatric Stem Cell Transplants: Report of a Recent Cluster and the Development of a Screening Protocol.
Larochelle MB; Phan R; Craddock J; Abzug MJ; Curtis D; Robinson CC; Giller RH; Cosgrove S; Siringo F; McCourt E; Palestine AG
Am J Ophthalmol; 2017 Mar; 175():8-15. PubMed ID: 27746296
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus retinitis after hematopoietic stem cell transplantation with alemtuzumab.
Song WK; Min YH; Kim YR; Lee SC
Ophthalmology; 2008 Oct; 115(10):1766-70. PubMed ID: 18562004
[TBL] [Abstract][Full Text] [Related]
9. High ocular CMV copies and mismatched receipts may predict poor visual prognosis in CMV retinitis patients following allogeneic haematopoietic stem cell transplantation.
Zhang Y; Ruan X; Yang W; Li L; Xian Z; Feng Q; Mo W
BMC Ophthalmol; 2017 Nov; 17(1):224. PubMed ID: 29187167
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
11. Ocular manifestations of HIV infection.
Jabs DA
Trans Am Ophthalmol Soc; 1995; 93():623-83. PubMed ID: 8719695
[TBL] [Abstract][Full Text] [Related]
12. [Cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) and related risk factors].
Huang XJ; Xu LP; Ren HY; Zhang YC; Guo NL; Lu DP
Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):766-9. PubMed ID: 12899755
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of risk factors for secondary cytopenia after allogeneic hematopoietic stem cell transplantation].
Lin Z; Kong Y; Wang Y; Zhang X; Liu D; Xu L; Huang X
Zhonghua Xue Ye Xue Za Zhi; 2014 Jan; 35(1):4-8. PubMed ID: 24602722
[TBL] [Abstract][Full Text] [Related]
14. Virological, clinical, and ophthalmologic features of cytomegalovirus retinitis after hematopoietic stem cell transplantation.
Crippa F; Corey L; Chuang EL; Sale G; Boeckh M
Clin Infect Dis; 2001 Jan; 32(2):214-9. PubMed ID: 11170910
[TBL] [Abstract][Full Text] [Related]
15. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K
Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656
[TBL] [Abstract][Full Text] [Related]
16. [Cytomegalovirus retinitis and ocular complications in AIDS patients in Togo].
Balo KP; Amoussou YP; Béchetoille A; Mihluedo H; Djagnikpo PA; Akpandja SM; Banla M
J Fr Ophtalmol; 1999 Dec; 22(10):1042-6. PubMed ID: 10617841
[TBL] [Abstract][Full Text] [Related]
17. Is cytomegalovirus testing of blood products still needed for hematopoietic stem cell transplant recipients in the era of universal leukoreduction?
Kekre N; Tokessy M; Mallick R; McDiarmid S; Huebsch L; Bredeson C; Allan D; Tay J; Tinmouth A; Sheppard D
Biol Blood Marrow Transplant; 2013 Dec; 19(12):1719-24. PubMed ID: 24099958
[TBL] [Abstract][Full Text] [Related]
18. Outcome and risk factors for late-onset complications 24 months beyond allogeneic hematopoietic stem cell transplantation.
Bieri S; Roosnek E; Ozsahin H; Huguet S; Ansari M; Trombetti A; Helg C; Chapuis B; Miralbell R; Passweg J; Chalandon Y
Eur J Haematol; 2011 Aug; 87(2):138-47. PubMed ID: 21535161
[TBL] [Abstract][Full Text] [Related]
19. The significance of cytomegalovirus viremia at day 100 or more following allogeneic hematopoietic stem cell transplantation.
Rowe J; Grim SA; Peace D; Lai C; Sweiss K; Layden JE; Clark NM
Clin Transplant; 2013; 27(4):510-6. PubMed ID: 23621704
[TBL] [Abstract][Full Text] [Related]
20. Ocular graft-versus-host disease after allogeneic stem cell transplantation.
Westeneng AC; Hettinga Y; Lokhorst H; Verdonck L; van Dorp S; Rothova A
Cornea; 2010 Jul; 29(7):758-63. PubMed ID: 20489577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
